T3 · Product exporter position

India exports of Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale (HS 300449)

See where India stands in medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (inn) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale: export scale, destination breadth, market position, growth, and reported trade history.

Explore this product View destinations

Exporter INDHS6 300449Latest year 2024Growing

Latest exports

$425.5MLatest observed lane total

Destination markets

159Reported active markets

Three-year growth

+5.7%Annualized change

Destination HHI

6,021Destination concentration

Weighted share

23%Reported market position

Exporter evidence

How strong is India in Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale?

Reported exporter totals and calculated indicators for HS 300449. Values retain their observed coverage period.

Exporter scale

Latest exports$425.5M

Current 2024 exports$424.1M

Three-year average$377.2M

Historical peak$691.5M

Market position

Active destinations159

Destination HHI6,021

Weighted share23%

Share change+2.5 pp

Competitiveness

Three-year growth+5.7%

Volatility1.1

Maximum drawdown96.8%

TrendGrowing

Measure	Value	What it describes
Exporter	India	Country represented by this profile
Latest observed exports	$425.5M	Sum of latest observed destination-lane values
Current 2024 exports	$424.1M	Common-year comparison where reported
Three-year growth	+5.7%	Annualized change in exporter totals
Five-year growth	+13.3%	Annualized change in exporter totals
Leading destination	USA	Destination with the largest observed export value
Leading destination share	77.4%	Share of observed exporter totals
Destination concentration	6,021	HHI across destination markets
Weighted share change	+2.5 pp	Value-weighted latest change in market share
Limited-history lanes	8.7%	Share of lanes with shorter history

Destination markets

Where does India sell medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (inn) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale?

Leading destination observations ranked by reported export value, with market position and access context.

Destination	Latest exports	Market share	Growth	Access	Signal
USA, Puerto Rico and US Virgin Islands	$329.1M	22%	+12.5%	0% tariff	Accelerating
South Africa	$18.7M	58.5%	+18.3%	0.1% tariff	Accelerating
United Kingdom	$9.4M	4.7%	+0.7%	Not reported	Growing
Australia	$9.1M	10.7%	-1.5%	0.1% tariff	Growing

Destination

USA, Puerto Rico and US Virgin Islands

Latest exports: $329.1M
Market share: 22%
Growth: +12.5%
Access: 0% tariff
Signal: Accelerating

Destination

South Africa

Latest exports: $18.7M
Market share: 58.5%
Growth: +18.3%
Access: 0.1% tariff
Signal: Accelerating

Destination

United Kingdom

Latest exports: $9.4M
Market share: 4.7%
Growth: +0.7%
Access: Not reported
Signal: Growing

Destination

Australia

Latest exports: $9.1M
Market share: 10.7%
Growth: -1.5%
Access: 0.1% tariff
Signal: Growing

Price intelligence

How does India's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

Jordan: $26.4M / ton.

Lowest reported price

Maldives: $756.5 / ton.

Median price

$35.9K / ton across reported markets.

Export trend

Reported export history

Annual observations for India and HS 300449 where available.

Year	Exports	Year-on-year change	Active destinations
2010	$168.4M	+24.1%	128
2011	$260.6M	+54.7%	129
2012	$235.0M	-9.8%	134
2013	$247.2M	+5.2%	133
2014	$258.5M	+4.6%	128
2015	$282.5M	+9.3%	137
2016	$300.3M	+6.3%	138
2017	$231.6M	-22.9%	131
2018	$240.2M	+3.7%	143
2019	$227.2M	-5.4%	137
2020	$256.6M	+12.9%	151
2021	$359.5M	+40.1%	154
2022	$336.3M	-6.4%	163
2023	$371.2M	+10.4%	166
2024	$424.1M	+14.3%	159

Exporter context

India economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300449.

India has reported exports of $434.2B and a trade balance of -$221.5B in 2024.

Available structural indicators include 24.9% trade openness, 35.7% investment, and 270 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about India medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (inn) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.